- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00196053
The Effectiveness of Pain Management Using the ARCHIMEDES® Constant-Flow Infusion Pump System for Intrathecal Delivery
Observational Registry: The Effectiveness of Pain Management Using the ARCHIMEDES® Implantable Constant-Flow Infusion Pump System for Intrathecal Delivery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Pain management has been a long-standing challenge to the medical community, specifically for the treatment of chronic pain. Chronic Pain is defined by the American Chronic Pain Association as "pain that continues a month or more beyond the usual recovery period for an illness or injury or pain that goes on over months or years as a result of a chronic condition." Chronic pain affects the patient's quality of life, work performance and attendance, mental health, social interactions and overall activities of daily living.
Implantable pumps were used for cancer and non-cancer patients, who had pain, which was resistant to conventional therapy. Intrathecal morphine administration is now accepted as a safe and effective method of controlling or reducing pain and its impact on the sufferer.
The Codman ARCHIMEDES Implantable Constant-Flow Infusion Pump is CE marked, and has been commercially available in Europe for intrathecal delivery of morphine and baclofen since August 1997. ARCHIMEDES is intended for the treatment of chronic intractable (cancer or non-cancer) pain, which requires chronic intrathecal infusion of preservative-free morphine sulfate.
This is a European, multicenter, prospective, single arm, observational registry conducted on a total of 150 Subjects at up to 10 centers in Europe.
Subjects will be followed at 3, 6, 9, and 12 months post Archimedes implant to assess their pain management and quality of life.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Laon, France, 02000
-
-
-
-
-
Bamberg, Germany, 81677
-
Freiburg, Germany, 79106
-
Konstanz, Germany, 78461
-
Meppen, Germany, 49704
-
Tutzing, Germany, 82327
-
-
-
-
-
Middlesbrough, United Kingdom, TS4 3BW
-
Plymoth, United Kingdom, PL6 8DH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The Subject has been suffering from chronic (benign and/or malignant) intractable pain for at least 2 or more months duration (pending national laws) with a pre-implant value equal or more than 7 on the Visual Analog Pain Scale.
- The subject does not tolerate oral pain medication at the required therapeutic dose to treat his/her pain.
- The Subject has a minimum reasonable life expectancy of at least 6 months.
- The Subject has given written Informed Consent prior to enrollment into this study.
- The body size of the Subject is sufficient to accept the pump bulk and weight, per the Principal Investigator's discretion.
- The Subject is willing to participate in this registry for 1 year post implant and is willing to comply with the investigational plan requirements.
- It is the Principal Investigator's judgment, based on the knowledge of the Subject, and Subject's condition, as well as the features of the implantable system that the Subject is an appropriate candidate for pain management utilizing an implantable pump for continuously delivering preservative-free morphine sulfate via an intrathecal route.
Exclusion Criteria:
- The Subject has a skin condition (i.e., scleroderma, psoriasis, rash, or open wound) at the site chosen for implantation that would compromise the integrity or access to the injection port.
- The Subject has previously enrolled in or participated in an investigational drug or device trial within the preceding 4 weeks.
- The Subject has any known contraindication to preservative-free morphine sulfate.
- The Subject has a suspected or documented allergy to preservative-free morphine sulfate or related drugs.
- The Subject has a suspected or documented allergy to the materials of the infusion pump or catheter(s) (for example, silicone).
- The Subject has a history of drug and/or alcohol abuse per Principal Investigator discretion.
- The Subject is a female who is pregnant or lactating.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Pain management measured by the visual analog pain scale
Time Frame: Quarterly for 1 year post-implant
|
Quarterly for 1 year post-implant
|
Pain management measured by quality of life score (SF-36)
Time Frame: Quarterly for 1 year post-implant
|
Quarterly for 1 year post-implant
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Device-related adverse events over the duration of the study
Time Frame: End of trial
|
End of trial
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Michael Ward, DVM, unaffilliated
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DDS-EU04-001
- EU Pain Registry
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pain
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaboratorsCompletedChronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain HipUnited Kingdom
-
Consorci Sanitari de l'Alt Penedès i GarrafRecruitingChronic Post Operative Pain | Chronic Post-surgical Pain | Chronic Knee PainSpain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
University of Alabama, TuscaloosaPatient-Centered Outcomes Research Institute; East Carolina University; Whatley...CompletedPain | Chronic Pain | Chronic Pain Syndrome | Widespread Chronic Pain | Chronic Pain Due to InjuryUnited States
-
University of UtahRecruitingChronic Pain | Chronic Pain Syndrome | Widespread Chronic PainUnited States
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Evolve Restorative CenterFlowonix Medical; Celéri Health, Inc.; Advanced Infusion SolutionsCompletedPain, Chronic | Pain, Intractable | Chronic Nonmalignant PainUnited States
-
Assiut UniversityNot yet recruiting
-
Vastra Gotaland RegionActive, not recruitingPain, Chronic | Widespread Chronic PainSweden
-
Washington University School of MedicineCompletedHip Pain Chronic | Back Pain | Chronic Pain | Knee Pain ChronicUnited States
Clinical Trials on Archimedes Constant Flow Implantable Pump
-
Cerenovus, Part of DePuy Synthes Products, Inc.No longer available
-
Institut Cancerologie de l'OuestCompletedAdvanced Cancer | Intractable PainFrance
-
François LelloucheUnknownSurgery | COPD Exacerbation | Abdominal Obesity | Oxygen ToxicityCanada
-
Association Nationale pour les Traitements A Domicile...CompletedChronic Obstructive Pulmonary DiseaseFrance
-
Nuwellis, Inc.Terminated
-
Cerebral Therapeutics LLCTerminated
-
Flowonix MedicalWithdrawn
-
Medtronic DiabetesCompletedType 1 DiabetesUnited States
-
National Cancer Institute (NCI)RecruitingColorectal Cancer | Liver Metastases | Colorectal Carcinoma | Colorectal Adenocarcinoma | Colorectal Cancer With Hepatic MetastasesUnited States
-
Laval UniversityFonds de la Recherche en Santé du Québec; Canada Foundation for InnovationCompletedExercise | COPD | Endurance Shuttle Walking Test (Exercise at 85% of Maximal Shuttle Walking Test)Canada